Lackner Mark 4
4 · IDEAYA Biosciences, Inc. · Filed Feb 10, 2021
Insider Transaction Report
Form 4
Lackner Mark
SVP, Head of Biology
Transactions
- Exercise/Conversion
Common Stock
2021-02-08$6.98/sh+300$2,094→ 300 total - Sale
Common Stock
2021-02-08$21.02/sh−100$2,102→ 200 total - Sale
Common Stock
2021-02-08$21.00/sh−200$4,200→ 0 total - Exercise/Conversion
Common Stock
2021-02-10$6.98/sh+596$4,160→ 596 total - Exercise/Conversion
Stock Option (right to buy)
2021-02-10−596→ 33,014 totalExercise: $6.98Exp: 2028-12-11→ Common Stock (596 underlying) - Sale
Common Stock
2021-02-09$21.05/sh−1,104$23,234→ 0 total - Sale
Common Stock
2021-02-10$21.00/sh−596$12,516→ 0 total - Exercise/Conversion
Stock Option (right to buy)
2021-02-08−300→ 34,714 totalExercise: $6.98Exp: 2028-12-11→ Common Stock (300 underlying) - Exercise/Conversion
Stock Option (right to buy)
2021-02-09−1,104→ 33,610 totalExercise: $6.98Exp: 2028-12-11→ Common Stock (1,104 underlying) - Exercise/Conversion
Common Stock
2021-02-09$6.98/sh+1,104$7,706→ 1,104 total
Footnotes (3)
- [F1]The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
- [F2]This transaction was executed in multiple trades in prices ranging from $21.00 to $21.11, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F3]25% of the shares subject to the option vest on the first anniversary measured from December 11, 2018 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.